Cowen analyst Yaron Werber raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $116.00 (from $90.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Ultragenyx Pharma (RARE) Prices 4.44M Share Common Offering at $90/ShOctober 29, 2020 5:54 AM Ultragenyx Pharma (RARE) PT Raised to $105 at WedbushOctober 28, 2020 6:28 AM Ultragenyx Pharma (RARE) PT Raised to $121 at BarclaysOctober 28, 2020 4:59 AM Ultragenyx Pharma (RARE) Tops Q3 EPS by 14c, Revenues BeatOctober 27, 2020 4:45 PM Form 10-Q Ultragenyx Pharmaceutica For: Sep 30October 27, 2020 4:21 PM Form 8-K Ultragenyx Pharmaceutica For: Oct 27October 27, 2020 4:08 PM Ultragenyx Reports Third Quarter 2020 Financial Results and Corporate UpdateOctober 27, 2020 4:06 PM